Breast Cancer Clinical Trial

Virtual Reality Software to Reduce Stress in Cancer Patients

Summary

The purpose of this study is to test the ability of virtual reality-based social support to increase patient adherence to radiation therapy by reducing patient distress.

View Full Description

Full Description

This study will involve patients who have been diagnosed with breast or head and neck cancer and are suitable to receive radiation therapy. It is a single arm pilot trial designed to provide information on the safety, feasibility, and impacts of incorporating virtual reality (VR) software into the treatment plan of patients receiving radiation therapy with the goal of increasing patient adherence to radiation therapy.

Patients will be provided with VR-based education sessions prior to and during the course of radiation therapy. Patients' emotional and social distress levels will be assessed with questionnaires to measure the impacts of the VR software. Patients will be in the study for up to 3 months during regular cancer care, but the total time for the study procedures is anticipated to be 2-4 hours in total. Results from this study will be for research only and will not impact treatment decisions.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age ≥ 18 years old
Must be able to read and speak English
Diagnosis of breast or head and neck cancer
Treatment plan includes radiotherapy within the next 2 months
Signed study-specific informed consent prior to study entry

Exclusion Criteria:

Previous radiation therapy treatment
Neurologic deficits
Visual disorder
Neuro-psychiatric disorder
Use of neuro-psychiatric drugs

Study is for people with:

Breast Cancer

Estimated Enrollment:

20

Study ID:

NCT05263648

Recruitment Status:

Not yet recruiting

Sponsor:

University of Oklahoma

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Oklahoma
Oklahoma City Oklahoma, 73104, United States More Info
Christina Henson, MD
Contact
405-271-3016
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

20

Study ID:

NCT05263648

Recruitment Status:

Not yet recruiting

Sponsor:


University of Oklahoma

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.